Skip to main content

Cost-of-illness analyses for policy making: A cautionary tale of use and misuse

Publication ,  Journal Article
Finkelstein, E; Corso, P
Published in: Expert Review of Pharmacoeconomics and Outcomes Research
August 1, 2003

In summary, we recognize that many current COI analyses suffer from both data and methodological shortcomings. However, we believe that a carefully conducted COI study that clearly documents all assumptions and limitations can minimize many of the concerns we have noted and provide valuable information. We caution against the misuse of COI estimates and wish to remind readers that efforts to equate costs to savings are misguided and that COI estimates should be only one of the many factors that decision-makers require to properly allocate resources. As additional data sets become available and researchers continue toward adoption of a common framework for conducting COI analyses, COI estimates will continue to improve and cross-study comparisons will be less problematic.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Expert Review of Pharmacoeconomics and Outcomes Research

DOI

ISSN

1473-7167

Publication Date

August 1, 2003

Volume

3

Issue

4

Start / End Page

367 / 369

Related Subject Headings

  • Health Policy & Services
  • 3801 Applied economics
  • 3214 Pharmacology and pharmaceutical sciences
  • 1402 Applied Economics
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Finkelstein, E., & Corso, P. (2003). Cost-of-illness analyses for policy making: A cautionary tale of use and misuse. Expert Review of Pharmacoeconomics and Outcomes Research, 3(4), 367–369. https://doi.org/10.1586/14737167.3.4.367
Finkelstein, E., and P. Corso. “Cost-of-illness analyses for policy making: A cautionary tale of use and misuse.” Expert Review of Pharmacoeconomics and Outcomes Research 3, no. 4 (August 1, 2003): 367–69. https://doi.org/10.1586/14737167.3.4.367.
Finkelstein E, Corso P. Cost-of-illness analyses for policy making: A cautionary tale of use and misuse. Expert Review of Pharmacoeconomics and Outcomes Research. 2003 Aug 1;3(4):367–9.
Finkelstein, E., and P. Corso. “Cost-of-illness analyses for policy making: A cautionary tale of use and misuse.” Expert Review of Pharmacoeconomics and Outcomes Research, vol. 3, no. 4, Aug. 2003, pp. 367–69. Scopus, doi:10.1586/14737167.3.4.367.
Finkelstein E, Corso P. Cost-of-illness analyses for policy making: A cautionary tale of use and misuse. Expert Review of Pharmacoeconomics and Outcomes Research. 2003 Aug 1;3(4):367–369.

Published In

Expert Review of Pharmacoeconomics and Outcomes Research

DOI

ISSN

1473-7167

Publication Date

August 1, 2003

Volume

3

Issue

4

Start / End Page

367 / 369

Related Subject Headings

  • Health Policy & Services
  • 3801 Applied economics
  • 3214 Pharmacology and pharmaceutical sciences
  • 1402 Applied Economics
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences